BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2008
View Archived Issues
Experiments reveal anticancer mechanisms of CXCR4 antagonists
Read More
Evidence of activity seen with CP-751871 in phase I sarcoma study
Read More
New agents for dermatitis disclosed in recent Kyowa Hakko Kirin patent
Read More
New therapeutic agents for eye disorders imparted in recent Santen patent
Read More
Recent patents describe novel treatments for neurological disorders
Read More
BIBW-2992 evaluated in combination with paclitaxel for solid tumors
Read More
Sirion presents pivotal uveitis data for Durezol
Read More
Cleveland BioLabs doses first healthy volunteer in Protectan CBLB-502 study
Read More
Development of BI-2536 in pancreatic cancer patients not warranted as a result of interim analysis
Read More
Grifols obtains marketing license for Flebogamma DIF in Australia
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Advanced BioHealing
Read More
Obesity candidate GRC-9332 described by Glenmark Pharmaceuticals
Read More
FDA to review Theravance's NDA for telavancin in treatment of cSSSI in November 2008
Read More
Seattle Genetics initiates phase I clinical trial of PSMA-targeted ADC in prostate cancer
Read More
MHRA grants approval to Insmed for phase I clinical study of INS-20
Read More
Wyeth not to pursue European MAA for desvenlafaxine in MDD
Read More
NeoPharm signs CRADA with NINDS for research on IL-13 in untreatable brain diseases
Read More
Invitrogen and Applied Biosystems amend merger agreement to eliminate tax opinion condition
Read More
Genzyme initiates enrollment in clinical trial of low-dose Fabrazyme in Fabry's disease
Read More
Alcon signs licensing agreement with GSK for cilomilast and expands alliance with Origenis
Read More
Advaxis provides complete response to FDA regarding IND for phase II trial of Lovaxin C
Read More
Bayer Schering Pharma completes decentralized approval procedure in EU for Qlaira
Read More
FDA grants orphan drug status to Reata's RTA-402 for pancreatic cancer
Read More
GlaxoSmithKline obtains approval in Japan for Lamictal in epilepsy
Read More
Lorus receives milestone payment from Zor and extends license agreement for Virulizin
Read More
